Search

James J. Collins III, Ph.D., Associate Professor of Pharmacology at UT Southwestern Medical Center who leads groundbreaking research into the parasitic disease schistosomiasis, has been named a Howard Hughes Medical Institute (HHMI) Investigator.

UT Southwestern Medical Center is collaborating with Pfizer Inc. to develop RNA enhanced delivery technologies for genetic medicine therapies through the Dallas-based medical center’s Program in Genetic Drug Engineering.

Two studies led by the Chahrour Lab at UT Southwestern Medical Center shed new light on genes associated with autism spectrum disorder (ASD), the neurodevelopmental disease characterized by impaired communication, abnormal social interactions, and restricted, repetitive behaviors.

Neurons in a part of the brain known as the ventromedial hypothalamus (VMH) appear to direct the body to boost endurance in response to exercise, a study co-led by researchers at UT Southwestern Medical Center shows.

Restricting calories has long been recognized as a powerful way to live longer, with periods of intermittent fasting proving more effective than a steady diet. However, the mechanism behind this phenomenon has been unclear.

New national guidance for managing cholesterol and other blood lipids calls for earlier risk assessment, more personalized treatment, and renewed emphasis on long-term cardiovascular prevention – changes experts say could significantly reduce heart attacks and strokes over a lifetime.

UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness.

UT Southwestern Medical Center is one of the 10 best large employers in the United States and among the top 5 health care employers, according to the America’s Best Employers 2022 list compiled by Forbes and Statista.

A cognitive behavioral therapy (CBT) program developed for parents whose child was born prematurely reduced harmful perceptions that their child remained medically fragile, according to a new study led by UT Southwestern Medical Center.

UT Southwestern Medical Center has completed a five-year, $1 billion campaign to fuel its commitment to advance brain research and clinical care at its Peter O’Donnell Jr. Brain Institute, making it one of the largest brain-focused investments at a U.S. academic medical center.